Here we discuss the therapeutic role of HO-1 in obesity, hypertension, atherosclerosis, Parkinson’s disease and hepatic fibrosis, and present important signaling pathway components that lead to HO-1 expression. This evidence concerns the gene HMOX1 and obesity due to melanocortin 4 receptor deficiency.